These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24013530)

  • 41. How to interpret data from the superficial femoral artery stenting trials and registries.
    Lin PH; Weakley SM; Kougias P
    Semin Vasc Surg; 2010 Sep; 23(3):138-47. PubMed ID: 20826290
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of demographic factors and lesion severity on iliac stent patency.
    Roach AN; Larion S; Ahanchi SS; Ammar CP; Brandt CT; Dexter DJ; Panneton JM
    J Vasc Surg; 2015 Sep; 62(3):645-53. PubMed ID: 26094046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use.
    Klein AJ; Feldman DN; Aronow HD; Gray BH; Gupta K; Gigliotti OS; Jaff MR; Bersin RM; White CJ;
    Catheter Cardiovasc Interv; 2014 Oct; 84(4):520-8. PubMed ID: 24740523
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Is there an alternative to the surgical above-knee bypass in treatment of superficial femoral artery disease? Experiences with Viabahn stent graft.
    Jebran AF; Popov AF; Zenker D; Bireta C; Friedrich M; Danner BC; Bougioukas I; Schoendube FA; Stojanovic T
    Vasc Endovascular Surg; 2013 Oct; 47(7):502-6. PubMed ID: 23867203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CTO of the SFA: what is the best approach?
    Safian RD
    Catheter Cardiovasc Interv; 2013 Sep; 82(3):493-4. PubMed ID: 24038980
    [No Abstract]   [Full Text] [Related]  

  • 46. Ever done or moving on?
    Misra S
    J Vasc Interv Radiol; 2012 Oct; 23(10):1322-3. PubMed ID: 22999750
    [No Abstract]   [Full Text] [Related]  

  • 47. PCR Peripheral @ GISE: a unique educational link between peripheral endovascular solutions and interventional cardiologists.
    Nicosia A; Cernetti C; Cremonesi A; Goktekin O; Sauguet A; Wijns W; Musumeci G
    EuroIntervention; 2017 Oct; 13(9):e1013-e1017. PubMed ID: 29033385
    [No Abstract]   [Full Text] [Related]  

  • 48. Absorbable Drug Eluting Stents May Bring LIFE to the Treatment of Below the Knee Lesions in Peripheral Arterial Disease.
    Nordanstig J; Mani K
    Eur J Vasc Endovasc Surg; 2024 Aug; 68(2):146-148. PubMed ID: 38762042
    [No Abstract]   [Full Text] [Related]  

  • 49. Commentary: nitinol stent designs need to adhere to the 3Bs: biofunctionality, biodurability, and biocompatibility.
    Guidoin R; Zhang Z; Douville Y; Nutley M
    J Endovasc Ther; 2014 Apr; 21(2):240-2. PubMed ID: 24754283
    [No Abstract]   [Full Text] [Related]  

  • 50. Technical endovascular highlights for crossing the difficult aortic bifurcation.
    Grenon SM; Reilly LM; Ramaiah VG
    J Vasc Surg; 2011 Sep; 54(3):893-6. PubMed ID: 21664094
    [TBL] [Abstract][Full Text] [Related]  

  • 51. New tools in endovascular surgery.
    Setacci C; Galzerano G; Setacci F; Mele M; Guerrini S; De Donato G
    J Cardiovasc Surg (Torino); 2016 Dec; 57(6):747-749. PubMed ID: 27654101
    [No Abstract]   [Full Text] [Related]  

  • 52. The superficial femoral artery conundrum: so close, yet so far away!
    Tsai TT
    JACC Cardiovasc Interv; 2014 Jul; 7(7):799-800. PubMed ID: 25060025
    [No Abstract]   [Full Text] [Related]  

  • 53. Endovascular challenges for complex lower extremity lesions?
    Deloose K
    J Cardiovasc Surg (Torino); 2015 Feb; 56(1):19-22. PubMed ID: 25579472
    [No Abstract]   [Full Text] [Related]  

  • 54. Contemporary endovascular management of common femoral artery atherosclerotic disease.
    Saratzis A; Stavroulakis K
    Br J Surg; 2021 Aug; 108(8):882-884. PubMed ID: 33984124
    [No Abstract]   [Full Text] [Related]  

  • 55. Towards the Application of Endovascular Treatment for Superficial Femoral Artery.
    Murakami A
    Circ J; 2018 Apr; 82(5):1253-1254. PubMed ID: 29607985
    [No Abstract]   [Full Text] [Related]  

  • 56. Progress in peripheral arterial disease.
    Patel RAG; White CJ
    Prog Cardiovasc Dis; 2021; 65():1. PubMed ID: 33766655
    [No Abstract]   [Full Text] [Related]  

  • 57. Reply: Inflammatory Cytokine Levels After Endovascular Therapy in Patients With Peripheral Artery Disease.
    Ueki Y; Miura T; Miyashita Y; Ebisawa S; Motoki H; Izawa A; Koyama J; Ikeda U
    Angiology; 2017 Sep; 68(8):742. PubMed ID: 28464699
    [No Abstract]   [Full Text] [Related]  

  • 58. The endovascular revolution continues!
    Varcoe RL
    J Cardiovasc Surg (Torino); 2019 Feb; 60(1):1-2. PubMed ID: 30417633
    [No Abstract]   [Full Text] [Related]  

  • 59. Coming of Age for Device Therapy in Peripheral Artery Disease.
    Beckman JA
    N Engl J Med; 2024 Jan; 390(1):78-79. PubMed ID: 38169493
    [No Abstract]   [Full Text] [Related]  

  • 60. Peripheral arterial disease: diagnosis and management.
    Ranson P
    Nurs Times; 2012 Oct 30-Nov 5; 108(44):23. PubMed ID: 23243805
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.